Thrombolex announces a never-before-reported significant reduction in obstruction in every single named segmental pulmonary artery from the Prospective Multicenter RESCUE Trial with the BASHIR™ Endovascular Catheter in a manuscript published in the Journal of the American College of Cardiology (JACC): Advances (online). The major reductions in obstruction in all of the segmental pulmonary arteries were based on an independent core lab data analysis of 107 patients from 18 sites in the US with acute intermediate-risk pulmonary embolism using the BASHIR™ Endovascular Catheter and small doses of tPA. The NIH-sponsored RESCUE trial also showed unsurpassed efficacy and safety in treating this patient population compared to recently published studies with other FDA-cleared devices. Learn more at https://lnkd.in/g2UmzBux Thrombolex.com #Thrombolex
Thrombolex, Inc.’s Post
More Relevant Posts
-
Join us today at 12:15 PM for our PERT Industry Satellite Session, Single Session Low-Dose Pharmacomechanical Lysis (PML) Therapy for Pulmonary Embolism: An Examination of Outcomes, featuring Dr. Eric Secemsky, Dr. Kenneth Rosenfield, Dr. Wissam Jaber, and Dr. Soophia Naydenov. Thrombolex.com #Thrombolex #PERT
-
-
Join us 9/12 at 12:15 PM as industry experts Dr. Eric Secemsky, Dr. Kenneth Rosenfield, Dr. Wissam Jaber, and Dr. Soophia Naydenov discuss where innovation meets excellence in the treatment of Pulmonary Embolism. Thrombolex.com #Thrombolex #PERTconsortium
-
-
Thrombolex is proud to support a Hands-on Physicians-in-Training Bootcamp at the PERT Consortium starting at 1pm on 9/11. Learn more at https://lnkd.in/eSV7uZFH #Thrombolex #PERT2024
-
-
Visit Thrombolex at booth 100 this week during PERT 2024 in Boston to learn more about our approach to acute PE treatment with the easy-to-use, single session PML technology of the BASHIR™ Endovascular Catheter. Thrombolex.com #Thrombolex #PERT2024
-
-
Experience the efficiency of the BASHIR™ .035 Endovascular Catheter. With 0.035" guidewire compatibility, the Catheter helps streamline pulmonary embolism treatment, reducing procedure time and lytic dose. Discover more at Thrombolex.com. #Thrombolex
-
-
Happy Labor Day from all of us at Thrombolex. Thrombolex.com #Thrombolexh
-
-
Precision meets efficiency in pulmonary embolism treatment. The BASHIR™ Endovascular Catheter safely and effectively treats PE in less time while enhancing patient outcomes. Discover how this technology is changing the way many physicians treat PE. Thrombolex.com. #Thrombolex
-
-
The BASHIR™ Endovascular Catheter combines mechanical and pharmacological therapies to safely resolve acute pulmonary embolism. More than just an infusion catheter. Transform PE treatment with Thrombolex. Learn more at Thrombolex.com. #Thrombolex
-
-
The BASHIR™ Endovascular Catheter is engineered for rapid and effective PE treatment while minimizing procedure time and maximizing positive clinical outcomes. Learn more at Thrombolex.com. #Thrombolex
-
